Ask Questions (ASQ):Implementation of a Communication Intervention

Study summary

This clinical trial implements a communication intervention to improve patient-oncologist communication in the outpatient medical oncology setting. A communication brochure called the ASQ brochure may help patients prepare for the doctor visit by thinking through the questions that patients and patients' family want to ask the doctor.

Ask AI to explain this study

Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedBehavioral Intervention

The study team can explain what participation involves.

Who it may be forEarly-stage or resectable · Locally advanced · Metastatic or stage IV

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Aug 16, 2023 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?8 U.S. locations

Locations may change over time.

Who runs it?Barbara Ann Karmanos Cancer Institute

Study sponsor

Study overview

What this study is about

Purpose: Health Services Research
Study type: Interventional
Phase: Not applicable
Sponsor: Barbara Ann Karmanos Cancer Institute
Interventions being studied: Behavioral: Behavioral Intervention

Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Disease setting

Early-stage or resectable→Locally advanced→Metastatic or stage IV→

Treatment approach

Supportive or behavioral care→

Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

Adults 18 years of age or older
Have a first appointment to see a medical oncologist at a Karmanos Cancer Institute (KCC) site for medical/systemic treatment for a new, confirmed diagnosis of stages I-IV cancer
Speak and read English well enough to be able to understand consent documents
Given the diverse population seen at KCI, we will make attempts to recruit a representative sample. Our strategy will be simply to ask recruiters to make special attempts to recruit a representative sample. If that strategy fails after the first 10 patients we will build in requirements that at least 25% of the patients self-identify as non-White

Reasons someone may not be able to joinExclusion criteria

Not specified

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

Study sites

U.S. locations

Karmanos Cancer Institute at McLaren Bay RegionBay City, Michigan
Karmanos Cancer Institute at McLaren ClarkstonClarkston, Michigan
Karmanos Cancer InstituteDetroit, Michigan
Karmanos Cancer Institute at McLaren FlintFlint, Michigan
Karmanos Cancer Institute at McLaren MacombMount Clemens, Michigan
Karmanos Cancer Institute at McLaren Central MichiganMount Pleasant, Michigan
Karmanos Cancer Institute at McLaren Northern MichiganPetoskey, Michigan
Karmanos Cancer Institute at McLaren Port HuronPort Huron, Michigan

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 16, 2023. Always confirm current availability with the study team.

View original record ↗